Oculis Holding AG OCS
NASDAQ OCS
$12.17 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Oculis Holding AG (OCS) Total Current Liabilities (2021 - 2026)

Oculis Holding AG (OCS) posted quarterly Total Current Liabilities of $56.0 million for Q1 2026, up 27.65% year-over-year from $43.9 million in Q1 2025, and up 21.83% quarter-over-quarter from $46.0 million in Q4 2025.

Analysis

Oculis Holding AG (OCS) Total Current Liabilities (2021 - 2026) Analysis & Trends

Oculis Holding AG's Total Current Liabilities history runs 6 years deep, the most recent figure standing at $56.0 million for Q1 2026.

  • In Q1 2026, Total Current Liabilities rose 27.65% year-over-year to $56.0 million; the TTM figure through Mar 2026 stood at $56.0 million (up 27.65% YoY), while the FY2025 annual figure was $44.3 million, down 11.85% from the prior year.
  • Total Current Liabilities for Q1 2026 stood at $56.0 million, up from $46.0 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $56.0 million in Q1 2026, with the low at $12.5 million in Q4 2022.
  • The 5-year median for Total Current Liabilities is $32.0 million (2024), against an average of $33.8 million.
  • The sharpest annual moves came in 2022 and 2025: Total Current Liabilities surged 183.23% in 2022, then declined 8.95% in 2025.
  • Oculis Holding AG's Total Current Liabilities stood at $12.5 million in 2022, then jumped by 72.47% to $21.5 million in 2023, then soared by 134.65% to $50.5 million in 2024, then fell by 8.95% to $46.0 million in 2025, then advanced by 21.83% to $56.0 million in 2026.
  • Business Quant data shows OCS's Total Current Liabilities at $56.0 million in Q1 2026, $46.0 million in Q4 2025, and $42.2 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.58 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.53 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 354.06 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 2.12 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.51 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 630.93 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 438.74 Mn
10 Oculis Holding AG 634.75 Mn 345.87 Mn - 35.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 35.33 Mn
Mar 31, 2026 56.01 Mn
Dec 31, 2025 45.98 Mn
Sep 30, 2025 42.16 Mn
Jun 30, 2025 44.14 Mn
Mar 31, 2025 43.88 Mn
Dec 31, 2024 50.50 Mn
Sep 30, 2024 31.99 Mn
Jun 30, 2024 26.13 Mn
Mar 31, 2024 20.80 Mn
Dec 31, 2023 21.52 Mn
Sep 30, 2023 25.08 Mn
Jun 30, 2023 18.69 Mn
Dec 31, 2022 12.48 Mn
Dec 31, 2021 4.41 Mn